Latest News

March 7, 2008
Allegro Diagnostics Closes $4 Million Round to Develop and Commercialize Lung Cancer Molecular Diagnostics Based on Gene Expression

Contact Us

Allegro Diagnostics, Inc.
650 Albany Street
Boston, MA 02118
Telephone: 617-414-6990

Management Team

The Allegro Diagnostics team has extensive experience in life sciences, pulmonary medicine, genomics, and bioinformatics.

Dan Rippy

President and CEO

Dan Rippy has fifteen years of experience in general management and the life sciences, including business development, finance, and marketing for publicly traded companies as well as medium-sized and early stage firms. He previously worked for Johnson & Johnson and Bristol-Myers Squibb in medical devices and pharmaceuticals, as well as for DFB Pharmaceuticals, where he headed the corporate development department. Additionally, Mr. Rippy previously served as CEO of Macrocyclics, an early stage radiopharmaceuticals and radiodiagnostics company, and headed the mergers & acquisitions and business planning department for CellStar, a publicly traded wireless logistics and distribution company. Mr. Rippy holds an MBA in Finance and Marketing from Columbia Business School and a Master's degree in Health Science & Technology from the Harvard-MIT Division of Health Science & Technology.

Jerome Brody, MD

Chief Scientific Officer

Jerry Brody has extensive experience in pulmonary and gene expression research as Professor of Medicine and Director of the Pulmonary Center at the Boston University School of Medicine. Dr. Brody has an academic and research career spanning more than 40 years and is widely regarded as a thought leader in pulmonary medicine. His publications cover a wide range of topics in pulmonary medicine, including chronic obstructive pulmonary disease (COPD), inflammation, and lung cancer, gene expression in smokers and non-smokers, and the effects of smoking on the airway epithelial cell transcriptome, among others. Dr. Brody received his medical degree from the University of Illinois, did his internship at Michael Reese Hospital, and his residency at Michael Reese Hospital and the University of Oklahoma. Additionally, he did a fellowship at the University of Pennsylvania. Dr. Brody joined Boston University in 1973 from the University of Pennsylvania, where he was on faculty.

Avrum Spira, MD, MSc

Scientific and Clinical Advisor

Dr. Avrum Spira is Assistant Professor of Medicine, Pathology, and Laboratory Medicine and Adjunct Assistant Professor of Bioinformatics at the Boston University School of Medicine. Additionally, he serves as Director of the Bioinformatics and Systems Biology Program at the Boston University School of Medicine's Pulmonary Center. He is an attending physician at the Medical Intensive Care Unit and with the Pulmonary/Critical Care Interventional service at Boston Medical Center. Dr. Spira's laboratory research interests focus on applying high-throughput genomic and bioinformatic tools to the translational study of lung cancer and emphysema. He is funded as a Principal Investigator through the NIH and the Doris Duke Charitable Foundation. Dr. Spira received his medical degree from McGill University and did his internship and residency at the University of Toronto. He did his fellowship with Boston University. Dr. Spira received a Master's degree in Bioinformatics from the College of Engineering at Boston University.